Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease

ML Tas; M Nagtegaal; KCJM Kraal; GA Tytgat; NGGM Abeling; J Koster; SMF Pluijm; C.M. Zwaan; B Keizer; JJ Molenaar; MM Noesel

doi:10.1002/pbc.28061

Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease

ML Tas
, M Nagtegaal
, KCJM Kraal
, GA Tytgat
, NGGM Abeling
, J Koster
, SMF Pluijm
, C.M. Zwaan
, B Keizer
, JJ Molenaar
, MM Noesel

Pediatrics

External organisation

Research output: Contribution to journal › Article › Academic › peer-review

29 Citations (Scopus)

30 Downloads (Pure)

Original language	English
Journal	Pediatric Blood and Cancer
Volume	67
DOIs	https://doi.org/10.1002/pbc.28061
Publication status	Published - 2020

Research programs

EMC MM-02-54-03

Access to Document

10.1002/pbc.28061

REPUB_121874-OA.pdfFinal published version, 365 KB

Cite this

@article{9d7dcde2b220478997e437c34eb0a4f2,

title = "Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease",

author = "ML Tas and M Nagtegaal and KCJM Kraal and GA Tytgat and NGGM Abeling and J Koster and SMF Pluijm and C.M. Zwaan and B Keizer and JJ Molenaar and MM Noesel",

year = "2020",

doi = "10.1002/pbc.28061",

language = "English",

volume = "67",

}

TY - JOUR

T1 - Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease

AU - Tas, ML

AU - Nagtegaal, M

AU - Kraal, KCJM

AU - Tytgat, GA

AU - Abeling, NGGM

AU - Koster, J

AU - Pluijm, SMF

AU - Zwaan, C.M.

AU - Keizer, B

AU - Molenaar, JJ

AU - Noesel, MM

PY - 2020

Y1 - 2020

U2 - 10.1002/pbc.28061

DO - 10.1002/pbc.28061

M3 - Article

C2 - 31736229

SN - 1545-5009

VL - 67

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

ER -